e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Diffuse parenchymal lung disease III
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical and immunological parameters in patients with newly diagnosed sarcoidosis
N. Demyanenko, V. Romanov, S. Sheluhina, E. Shmelev, O. Lovacheva, M. Averbach (Moscow, Russian Federation)
Source:
Annual Congress 2013 –Diffuse parenchymal lung disease III
Session:
Diffuse parenchymal lung disease III
Session type:
Thematic Poster Session
Number:
3818
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Demyanenko, V. Romanov, S. Sheluhina, E. Shmelev, O. Lovacheva, M. Averbach (Moscow, Russian Federation). Clinical and immunological parameters in patients with newly diagnosed sarcoidosis. Eur Respir J 2013; 42: Suppl. 57, 3818
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Relationship between radiologic patterns, pulmonary function values and BALF cells in newly diagnosed sarcoidosis
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015
Clinical approach to pulmonary sarcoidosis
Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases
Year: 2016
Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease (DILDs)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
The role of the combined assessment of the bronchoalveolar lavage (BAL) and radiological profile in the diagnosis of chronic eosinophilic pneumonia (CEP)
Source: Annual Congress 2013 –Modern approach to various clinical settings
Year: 2013
Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful?
Source: Eur Respir J 2011; 38: 761-769
Year: 2011
Clinical significance of hemosiderin-laden macrophages in bronchoalveolar lavage fluid of patients with idiopathic interstitial pneumonias
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Retrospective assessment of pulmonary sarcoidosis with the aid of bronchoalveolar lavage (BAL) during the past three-year period in a general hospital
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Usefulness of bronchoalveolar lavage in the diagnosis of desquamative interstitial pneumonia
Source: International Congress 2014 – ILDs 2
Year: 2014
The impact of age on bronchoalveolar lavage (BAL) cytoimmunological pattern in interstitial lung diseases (ILD) and in healthy controls
Source: International Congress 2014 – ILDs 4
Year: 2014
Eosinophilic lung disease
Source: International Congress 2016 – Orphan diseases I
Year: 2016
Bronchoalveolar lavage in children with diffuse lung disease
Source: Annual Congress 2008 - The use of fibreoptic bronchoscopy in children with diffuse or localised lung disease
Year: 2008
Is the severity of newly diagnosed pulmonary sarcoidosis reflected by bronchoalveolar lavage (BAL) parameters?
Source: Eur Respir J 2001; 18: Suppl. 33, 507s
Year: 2001
Is the severity of newly diagnosed pulmonary sarcoidosis reflected by bronchoalveolar lavage (BAL) parameters?
Source: Eur Respir J 2002; 20: Suppl. 38, 468s
Year: 2002
Usefulness of anti-Ro52 antibodies in the BAL of the patients with ILDs. Pilot study
Source: International Congress 2016 – ILD pathogenesis
Year: 2016
Correlations between the bronchoalveolar lavage cytology and lung function stage in newly diagnosed sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 538s
Year: 2006
Bronchoalveolar lavage: how can we use it more effectively to define pathology?
Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases
Year: 2006
Bronchoalveolar lavage
Source: Eur Respir Mon; 2010: 48: 59–72
Year: 2010
Indication of whole lung lavage in pulmonary alveolar proteinosis – Retrospective study
Source: International Congress 2015 – IIPs: orphan
Year: 2015
Bronchoalveolar lavage immunophenotyping improves diagnostic accuracy in patients with diffuse parenchymal lung disease
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010
Clinical, computed tomography, and cytological peculiarities of different variants of exogenic allergic alveolitis (EAA)
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept